KemPharm Inc. | Ownership
Companies that own KemPharm Inc.
DSC Advisors LP
2,095,914
13.07%
304,283
4.5%
07/30/2018
Alyeska Investment Group LP
883,681
5.51%
-8,897
0.04%
06/30/2018
Arete Wealth Advisors LLC
515,112
3.21%
-45,870
0.61%
06/30/2018
Creative Planning, Inc.
451,814
2.82%
-1,709
0.01%
06/30/2018
The Vanguard Group, Inc.
435,735
2.72%
26,408
0%
06/30/2018
C WorldWide Asset Management Fondsmæglerselskab A/S
399,999
2.49%
12,319
0.02%
06/30/2018
Cowen Investment Management LLC
366,313
2.27%
366,313
0.81%
06/30/2018
Renaissance Technologies LLC
181,800
1.12%
91,400
0%
06/30/2018
Victory Capital Management, Inc.
170,667
1.06%
-9,070
0%
06/30/2018
Millennium Management LLC
151,250
0.94%
135,784
0%
06/30/2018
| Address |
1180 Celebration Boulevard
Celebration Florida 34747
United States
|
|
Employees
|
- |
| Website |
http://www.kempharm.com |
| Updated |
07/08/2019 |
| KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. |
